Aberrant immune responses are linked to cancer progression and transplantation rejection. EU-funded researchers worked on targeted immune modulation to improve patient outcomes.
Cancer progression occurs through suppression and evasion of anti-tumour immune responses. On the other hand, transplantation rejection is the result of immune response towards the transplanted organ.
Further details: Immune system modulation